US Stock MarketDetailed Quotes

FOLD Amicus Therapeutics

Watchlist
  • 9.800
  • +0.070+0.72%
Close Dec 20 16:00 ET
  • 9.800
  • 0.0000.00%
Post 20:01 ET
2.93BMarket Cap-28.82P/E (TTM)

About Amicus Therapeutics Company

Amicus Therapeutics, Inc. operates as a biotechnology company. The firm focuses on discovering, developing and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.

Company Profile

SymbolFOLD
Company NameAmicus Therapeutics
Listing DateMay 31, 2007
Issue Price15.00
Founded2002
CEOMr. Bradley L. Campbell
MarketNASDAQ
Employees517
Fiscal Year Ends12-31
Address47 Hulfish Street
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08542
Phone1-609-662-2000
Websitehttp://www.amicusrx.com

Company Executives

  • Name
  • Position
  • Salary
  • Bradley L. Campbell
  • Director, President and Chief Executive Officer
  • 8.20M
  • Samantha Prout
  • Chief Accounting Officer and Controller
  • --
  • Ellen S. Rosenberg
  • Chief Legal Officer, General Counsel and Corporate Secretary
  • 4.08M
  • David M. Clark
  • Chief People Officer
  • 3.21M
  • Jeffrey P. Castelli, PhD
  • Chief Development Officer
  • 3.67M
  • Simon Nicolas Reade Harford
  • Chief Financial Officer
  • 2.98M
  • Michael G. Raab
  • Lead Independent Director and Chairman of the Board
  • 426.25K
  • Dr. Eiry W. Roberts, M.D.
  • Independent Director
  • 390.00K
  • Margaret G. McGlynn
  • Independent Director
  • 401.25K
  • Glenn P. Sblendorio
  • Independent Director
  • 407.07K
  • Craig A. Wheeler
  • Independent Director
  • 398.50K
  • Burke W. Whitman
  • Independent Director
  • 391.25K
  • Michael A. Kelly
  • Independent Director
  • 391.25K
  • Lynn Dorsey Bleil
  • Independent Director
  • 397.50K
Heat List
US
Overall
Symbol
Price
% Chg

No Data